Literature DB >> 11870376

Intestinal mucosal alterations in experimental cirrhosis in the rat: role of oxygen free radicals.

Anup Ramachandran1, Ramamoorthy Prabhu, Simmy Thomas, Jayasree Basivi Reddy, Anna Pulimood, Kunissery A Balasubramanian.   

Abstract

Cirrhosis is associated with altered gastrointestinal function, and bacterial translocation from the gut plays an important role in the etiology of spontaneous bacterial peritonitis (SBP) seen in this condition. Although alterations in gut motility and intestinal permeability are recognized in cirrhosis, the intestinal damage at the cellular and subcellular levels is not well understood. This study looked at the mucosal alterations in experimental cirrhosis and the role of oxygen free radicals in this process. It was shown that cirrhosis results in oxidative stress in the intestine, as seen by increased xanthine oxidase (XO) activity and altered antioxidant status. Cirrhosis also affects enterocyte mitochondrial function, as assessed by respiratory control ratio, swelling, and calcium flux. Increased lipid peroxidation of the brush border membranes (BBMs) was seen along with altered intestinal transport. In conclusion, this study shows that intestinal mucosal alterations are seen in experimental cirrhosis and are possibly mediated by oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870376     DOI: 10.1053/jhep.2002.31656

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Intestinal permeability in rats with CCl4-induced portal hypertension.

Authors:  Guo-Xiang Yao; Zhong-Yi Shen; Xin-Bo Xue; Zhen Yang
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

Authors:  Sheng-Lan Wang; Xin-Yan Zhu; Dong-Wei Zhang; Zhao-Jie Zhang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  The effect of caffeic acid phenethyl ester on bacterial translocation and intestinal damage in cholestatic rats.

Authors:  Cengiz Ara; Mukaddes Esrefoglu; Alattin Polat; Burak Isik; Murat Aladag; Mehmet Gul; Selma Ay; M Sait Tekerleklioglu; Sezai Yilmaz
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

6.  Toll-like receptors as targets in chronic liver diseases.

Authors:  A Mencin; J Kluwe; R F Schwabe
Journal:  Gut       Date:  2009-05       Impact factor: 23.059

Review 7.  Spontaneous bacterial peritonitis.

Authors:  Anastasios Koulaouzidis; Shivaram Bhat; Athar A Saeed
Journal:  World J Gastroenterol       Date:  2009-03-07       Impact factor: 5.742

8.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

Review 9.  Alcoholic pancreatitis: A tale of spirits and bacteria.

Authors:  Alain Vonlaufen; Laurent Spahr; Minoti V Apte; Jean-Louis Frossard
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

Review 10.  Intestinal Barrier and Permeability in Health, Obesity and NAFLD.

Authors:  Piero Portincasa; Leonilde Bonfrate; Mohamad Khalil; Maria De Angelis; Francesco Maria Calabrese; Mauro D'Amato; David Q-H Wang; Agostino Di Ciaula
Journal:  Biomedicines       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.